BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.820
-0.040 (-1.40%)
Jul 24, 2026, 4:00 PM EDT - Market closed
BioLineRx Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.93 | 1.18 | 28.94 | 4.8 | - | - | |
Revenue Growth (YoY) | -95.86% | -95.92% | 502.92% | - | - | - |
Cost of Revenue | 0.29 | 0.23 | 9.26 | 3.69 | - | - |
Gross Profit | 1.11 | 0.95 | 19.68 | 1.11 | - | - |
Selling, General & Admin | 3.01 | 3.14 | 29.93 | 31.58 | 11.53 | 5.31 |
Research & Development | 9 | 8.09 | 9.15 | 12.52 | 17.63 | 19.47 |
Other Operating Expenses | - | - | 1.01 | 6.7 | - | - |
Total Operating Expenses | 12.01 | 11.24 | 40.09 | 50.8 | 29.16 | 24.78 |
Operating Income | -10.9 | -10.29 | -20.41 | -49.69 | -29.16 | -24.78 |
Interest Income | 1.38 | 1.46 | 1.87 | 2.07 | 0.69 | 0.56 |
Interest Expense | -1.11 | -1.28 | -9.12 | -2.17 | -2.16 | -1.01 |
Other Non-Operating Income (Expense) | 0.89 | 8.08 | 18.44 | -10.82 | 5.67 | -1.83 |
Total Non-Operating Income (Expense) | 1.16 | 8.26 | 11.19 | -10.92 | 4.21 | -2.28 |
Pretax Income | -9.74 | -2.03 | -9.22 | -60.61 | -24.95 | -27.05 |
Net Income | -2.59 | -2.03 | -9.22 | -60.61 | -24.95 | -27.05 |
Minority Interest in Earnings | -0.99 | - | - | - | - | - |
Net Income to Common | -1.6 | -2.03 | -9.22 | -60.61 | -24.95 | -27.05 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 4 | 4 | 2 | 2 | 1 | 1 |
Shares Outstanding (Diluted) | 4 | 4 | 2 | 2 | 1 | 1 |
Shares Change (YoY) | 73.89% | 105.76% | 24.37% | 24.47% | 16.75% | 162.19% |
EPS (Basic) | - | - | -6.00 | -36.00 | -18.00 | -24.00 |
EPS (Diluted) | - | - | -6.00 | -36.00 | -18.00 | -24.00 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -7.76 | -8.1 | -43.93 | -22.72 | -26.37 | -23.67 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -1.81 | -1.97 | -22.00 | -14.15 | -20.44 | -21.42 |
Gross Margin | 120.11% | 80.51% | 67.99% | 23.08% | - | - |
Operating Margin | -1178.38% | -871.78% | -70.52% | -1035.29% | - | - |
Profit Margin | -279.78% | -171.69% | -31.86% | -1262.79% | - | - |
FCF Margin | -839.24% | -686.36% | -151.78% | -473.42% | - | - |
EBITDA | -10.45 | -9.76 | -16.34 | -48.31 | -28.5 | -24.07 |
EBITDA Margin | -1130.16% | -827.46% | -56.47% | -1006.46% | - | - |
EBIT | -10.9 | -10.29 | -20.41 | -49.69 | -29.16 | -24.78 |
EBIT Margin | -1178.38% | -871.78% | -70.52% | -1035.29% | - | - |